COVID Vaccines | Chemo Brain | Persistent Poverty, Cancer Information Highlights, 11/16/2022

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
COVID-19 Vaccines Are Safe for People Receiving Immunotherapy
pair of gloved hands fills a syringe while a woman in a mask waits in the background   Some people with cancer are reluctant to get COVID-19 vaccines during treatment with immune checkpoint inhibitors for fear of side effects. But a study at Memorial Sloan Kettering Cancer Center found mRNA COVID-19 vaccines did not increase immune-related side effects among people taking these drugs.
Preventing Chemo Brain
  A new study in mice found that cisplatin causes high levels of a protein called S1P in the brain, which is thought to trigger the memory and thinking problems referred to as chemo brain. Multiple sclerosis drugs that target a brain receptor for S1P prevented chemo brain–like symptoms in mice treated with cisplatin. Learn how these findings might lead to new ways to treat or prevent chemo brain in people.
Persistent Poverty and Cancer
cover of NCI Annual Plan and Budget Proposal for Fiscal Year 2024   Recent research has shown that death rates from cancer in counties with persistent poverty are 12% higher than in other US counties. This section of the NCI Annual Plan & Budget Proposal for Fiscal Year 2024 describes how NCI is supporting research into this complex problem.

FDA Approvals
Cemiplimab-rwlc

We’ve updated our drug summary on cemiplimab-rwlc (Libtayo). The Food and Drug Administration recently approved this drug to be used with platinum chemotherapy as the first treatment for adults with advanced non-small cell lung cancer that does not have a mutation in the EGFR, ALK, or ROS1 gene.
 
Also of Interest
Text Message Programs to Help You Quit Smoking

November 17 is the Great American Smokeout. If you want to quit smoking, perhaps a text message program will help you succeed. Sign up for a practice quit or build your quitting skills with daily challenges.
Risk Factors for Cancer

It is often not possible to know why one person develops cancer and another doesn’t. But research has shown that certain risk factors may increase a person’s chances of developing cancer. This page links to more information about the most-studied or suspected risk factors for cancer.
Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.